UniProt ID | PRAX_HUMAN | |
---|---|---|
UniProt AC | Q9BXM0 | |
Protein Name | Periaxin | |
Gene Name | PRX | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1461 | |
Subcellular Localization |
Isoform 1: Cell membrane Peripheral membrane protein Cytoplasmic side . Nucleus . Cytoplasm . Detected in the Schwann cell nucleus prior to the onset of myelination. Detected in Schwann cells at periaxonal myelin membranes. Associated with the ce |
|
Protein Description | Scaffolding protein that functions as part of a dystroglycan complex in Schwann cells, and as part of EZR and AHNAK-containing complexes in eye lens fiber cells. Required for the maintenance of the peripheral myelin sheath that is essential for normal transmission of nerve impulses and normal perception of sensory stimuli. Required for normal transport of MBP mRNA from the perinuclear to the paranodal regions. Required for normal remyelination after nerve injury. Required for normal elongation of Schwann cells and normal length of the internodes between the nodes of Ranvier. The demyelinated nodes of Ranvier permit saltatory transmission of nerve impulses; shorter internodes cause slower transmission of nerve impulses. Required for the formation of appositions between the abaxonal surface of the myelin sheath and the Schwann cell plasma membrane; the Schwann cell cytoplasm is restricted to regions between these appositions. Required for the formation of Cajal bands and of Schmidt-Lanterman incisures that correspond to short, cytoplasm-filled regions on myelinated nerves. Recruits DRP2 to the Schwann cell plasma membrane. Required for normal protein composition of the eye lens fiber cell plasma membrane and normal eye lens fiber cell morphology.. | |
Protein Sequence | MEARSRSAEELRRAELVEIIVETEAQTGVSGINVAGGGKEGIFVRELREDSPAARSLSLQEGDQLLSARVFFENFKYEDALRLLQCAEPYKVSFCLKRTVPTGDLALRPGTVSGYEIKGPRAKVAKLNIQSLSPVKKKKMVPGALGVPADLAPVDVEFSFPKFSRLRRGLKAEAVKGPVPAAPARRRLQLPRLRVREVAEEAQAARLAAAAPPPRKAKVEAEVAAGARFTAPQVELVGPRLPGAEVGVPQVSAPKAAPSAEAAGGFALHLPTLGLGAPAPPAVEAPAVGIQVPQVELPALPSLPTLPTLPCLETREGAVSVVVPTLDVAAPTVGVDLALPGAEVEARGEAPEVALKMPRLSFPRFGARAKEVAEAKVAKVSPEARVKGPRLRMPTFGLSLLEPRPAAPEVVESKLKLPTIKMPSLGIGVSGPEVKVPKGPEVKLPKAPEVKLPKVPEAALPEVRLPEVELPKVSEMKLPKVPEMAVPEVRLPEVELPKVSEMKLPKVPEMAVPEVRLPEVQLLKVSEMKLPKVPEMAVPEVRLPEVQLPKVSEMKLPEVSEVAVPEVRLPEVQLPKVPEMKVPEMKLPKVPEMKLPEMKLPEVQLPKVPEMAVPDVHLPEVQLPKVPEMKLPEMKLPEVKLPKVPEMAVPDVHLPEVQLPKVPEMKLPKMPEMAVPEVRLPEVQLPKVSEMKLPKVPEMAVPDVHLPEVQLPKVCEMKVPDMKLPEIKLPKVPEMAVPDVHLPEVQLPKVSEIRLPEMQVPKVPDVHLPKAPEVKLPRAPEVQLKATKAEQAEGMEFGFKMPKMTMPKLGRAESPSRGKPGEAGAEVSGKLVTLPCLQPEVDGEAHVGVPSLTLPSVELDLPGALGLQGQVPAAKMGKGERVEGPEVAAGVREVGFRVPSVEIVTPQLPAVEIEEGRLEMIETKVKPSSKFSLPKFGLSGPKVAKAEAEGAGRATKLKVSKFAISLPKARVGAEAEAKGAGEAGLLPALDLSIPQLSLDAHLPSGKVEVAGADLKFKGPRFALPKFGVRGRDTEAAELVPGVAELEGKGWGWDGRVKMPKLKMPSFGLARGKEAEVQGDRASPGEKAESTAVQLKIPEVELVTLGAQEEGRAEGAVAVSGMQLSGLKVSTAGQVVTEGHDAGLRMPPLGISLPQVELTGFGEAGTPGQQAQSTVPSAEGTAGYRVQVPQVTLSLPGAQVAGGELLVGEGVFKMPTVTVPQLELDVGLSREAQAGEAATGEGGLRLKLPTLGARARVGGEGAEEQPPGAERTFCLSLPDVELSPSGGNHAEYQVAEGEGEAGHKLKVRLPRFGLVRAKEGAEEGEKAKSPKLRLPRVGFSQSEMVTGEGSPSPEEEEEEEEEGSGEGASGRRGRVRVRLPRVGLAAPSKASRGQEGDAAPKSPVREKSPKFRFPRVSLSPKARSGSGDQEEGGLRVRLPSVGFSETGAPGPARMEGAQAAAV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Phosphorylation | ---MEARSRSAEELR ---CCHHHCCHHHHH | 37.32 | 23403867 | |
7 | Phosphorylation | -MEARSRSAEELRRA -CCHHHCCHHHHHHH | 41.08 | 23403867 | |
58 | Phosphorylation | SPAARSLSLQEGDQL CCCHHHCCHHHHHHH | 29.29 | 28857561 | |
67 | Phosphorylation | QEGDQLLSARVFFEN HHHHHHHHHHHHHHC | 23.71 | 24719451 | |
99 | Phosphorylation | VSFCLKRTVPTGDLA EEEEEECCCCCCCEE | 29.29 | 24719451 | |
102 | Phosphorylation | CLKRTVPTGDLALRP EEECCCCCCCEEECC | 38.70 | - | |
111 | Phosphorylation | DLALRPGTVSGYEIK CEEECCCEECCEEEC | 17.74 | - | |
113 | Phosphorylation | ALRPGTVSGYEIKGP EECCCEECCEEECCC | 35.18 | - | |
115 | Phosphorylation | RPGTVSGYEIKGPRA CCCEECCEEECCCCC | 13.63 | 24719451 | |
132 (in isoform 2) | Phosphorylation | - | 3.72 | - | |
133 | Phosphorylation | KLNIQSLSPVKKKKM EEECCCCCCCCCCCC | 32.66 | 24719451 | |
145 (in isoform 2) | Phosphorylation | - | 9.84 | - | |
361 | Phosphorylation | ALKMPRLSFPRFGAR HHHCCCCCCCCCCHH | 34.19 | 24719451 | |
424 | Phosphorylation | LPTIKMPSLGIGVSG CCCCCCCCCCCCCCC | 35.41 | 24114839 | |
430 | Phosphorylation | PSLGIGVSGPEVKVP CCCCCCCCCCCCCCC | 43.34 | 23312004 | |
552 | Phosphorylation | EVQLPKVSEMKLPEV CCCCCCCCCCCCCCC | 37.79 | 29449344 | |
560 | Phosphorylation | EMKLPEVSEVAVPEV CCCCCCCCEEECCCC | 25.37 | 29449344 | |
805 | Phosphorylation | GFKMPKMTMPKLGRA CCCCCCCCCCCCCCC | 36.13 | 29759185 | |
900 | Phosphorylation | EVGFRVPSVEIVTPQ ECCEECCCEEEECCC | 29.53 | - | |
932 | Phosphorylation | VKPSSKFSLPKFGLS CCCCCCCCCCCCCCC | 47.72 | 24719451 | |
965 | Phosphorylation | KVSKFAISLPKARVG EEEEEEECCCHHHHC | 34.88 | 21815630 | |
1004 | Phosphorylation | SLDAHLPSGKVEVAG CEECCCCCCCEEECC | 58.57 | 24719451 | |
1082 | Phosphorylation | EVQGDRASPGEKAES EECCCCCCCCCCCCC | 34.04 | 28857561 | |
1089 | Phosphorylation | SPGEKAESTAVQLKI CCCCCCCCCEEEECC | 26.90 | 24702127 | |
1090 | Phosphorylation | PGEKAESTAVQLKIP CCCCCCCCEEEECCC | 23.50 | 24702127 | |
1119 | Phosphorylation | AEGAVAVSGMQLSGL CCCEEEEECEEECCC | 20.86 | - | |
1328 | Phosphorylation | EEGEKAKSPKLRLPR HCCCCCCCCCCCCCC | 31.93 | 20068231 | |
1349 | Phosphorylation | EMVTGEGSPSPEEEE HCCCCCCCCCHHHHH | 20.22 | - | |
1351 | Phosphorylation | VTGEGSPSPEEEEEE CCCCCCCCHHHHHHH | 46.79 | - | |
1363 | Phosphorylation | EEEEEEGSGEGASGR HHHHHCCCCCCCCCC | 36.63 | - | |
1387 | Phosphorylation | RVGLAAPSKASRGQE CCEEECCCCCCCCCC | 35.81 | 23403867 | |
1401 | Phosphorylation | EGDAAPKSPVREKSP CCCCCCCCCCCCCCC | 27.80 | 28857561 | |
1407 | Phosphorylation | KSPVREKSPKFRFPR CCCCCCCCCCCCCCC | 28.68 | 23911959 | |
1416 | Phosphorylation | KFRFPRVSLSPKARS CCCCCCCCCCCCCCC | 25.14 | 24719451 | |
1418 | Phosphorylation | RFPRVSLSPKARSGS CCCCCCCCCCCCCCC | 19.49 | 24719451 | |
1423 | Phosphorylation | SLSPKARSGSGDQEE CCCCCCCCCCCCCCC | 42.02 | 28796482 | |
1425 | Phosphorylation | SPKARSGSGDQEEGG CCCCCCCCCCCCCCC | 40.21 | 28796482 | |
1439 | Phosphorylation | GLRVRLPSVGFSETG CEEEECCCCCCCCCC | 39.19 | 28857561 | |
1445 | Phosphorylation | PSVGFSETGAPGPAR CCCCCCCCCCCCCCC | 37.13 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of PRAX_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PRAX_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PRAX_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DAG1_HUMAN | DAG1 | physical | 11430802 | |
DRP2_HUMAN | DRP2 | physical | 11430802 | |
PRAX_HUMAN | PRX | physical | 11430802 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
H00264 | Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atroph | |||||
OMIM Disease | ||||||
145900 | Dejerine-Sottas syndrome (DSS) | |||||
614895 | Charcot-Marie-Tooth disease 4F (CMT4F) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1328, AND MASSSPECTROMETRY. |